| Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma LS Cheung, J Fu, P Kumar, A Kumar, ME Urbanowski, EA Ihms, ... Proceedings of the National Academy of Sciences 116 (8), 3100-3105, 2019 | 63 | 2019 |
| Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy JRMWB Pankaj Kumar, Amit Kumar, Sadiya Parveen Immunotherapy 11 (13), 1117-1128, 2019 | 18 | 2019 |
| Kaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathway A Kumar, SK Sahu, S Mohanty, S Chakrabarti, S Maji, RR Reddy, AK Jha, ... PLoS One 9 (6), e100228, 2014 | 17 | 2014 |
| Multi-targeted therapy of everolimus in Kaposi’s sarcoma associated herpes virus infected primary effusion lymphoma S Mohanty, A Kumar, P Das, SK Sahu, T Choudhuri Apoptosis 22, 1098-1115, 2017 | 13 | 2017 |
| Association of p53 codon72 Arg> Pro polymorphism with susceptibility to nasopharyngeal carcinoma: evidence from a case–control study and meta-analysis SK Sahu, S Chakrabarti, SD Roy, N Baishya, RR Reddy, S Suklabaidya, ... Oncogenesis 5 (5), e225-e225, 2016 | 13 | 2016 |
| Proteomic analysis of the human anterior pituitary gland SD Yelamanchi, A Tyagi, V Mohanty, P Dutta, M Korbonits, S Chavan, ... Omics: a journal of integrative biology 22 (12), 759-769, 2018 | 12 | 2018 |
| Epstein–Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor SK Sahu, S Mohanty, A Kumar, CN Kundu, SC Verma, T Choudhuri Virology 448, 333-343, 2014 | 8 | 2014 |
| Role of Interleukin 28B polymorphisms in response to Interferon based therapy for hepatitis C virus clearance M Asthana, SK Sahu, A Kumar, S Mohanty, S Chakrabarti, P Das, ... Current Drug Metabolism 19 (3), 215-223, 2018 | 6 | 2018 |
| Targeting epigenetic regulation for cancer therapy using small molecule inhibitors A Kumar, L Emdad, PB Fisher, SK Das Advances in Cancer Research 158, 73-161, 2023 | 5 | 2023 |
| Insights into the mechanisms of action of MDA-7/IL-24: A ubiquitous cancer-suppressing protein J Modi, A Roy, AK Pradhan, A Kumar, S Talukdar, P Bhoopathi, S Maji, ... International Journal of Molecular Sciences 23 (1), 72, 2021 | 5 | 2021 |
| 1, 25 (OH) 2 D3 Induces Reactivation and Death of Kaposi’s Sarcoma-Associated Herpesvirus of Primary Effusion Lymphoma cells A Kumar, S Mohanty, P Das, SK Sahu, S Rajasubramaniam, T Choudhuri Scientific Reports 7 (1), 12438, 2017 | 5 | 2017 |
| CellNeighborEX: deciphering neighbor‐dependent gene expression from spatial transcriptomics data H Kim, A Kumar, C Lövkvist, AM Palma, P Martin, J Kim, P Bhoopathi, ... Molecular Systems Biology 19 (11), e11670, 2023 | 4 | 2023 |
| TAp63alpha induced apoptosis inhibited by Kaposi's sarcoma herpesvirus latency nuclear antigen S Mohanty, SK Sahu, NR Chattopadhyay, A Kumar, P Das, T Choudhuri J. Carcinog. Mutagen 6 (2), 2015 | 3 | 2015 |
| Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor AK Pradhan, P Bhoopathi, S Maji, A Kumar, C Guo, P Mannangatti, J Li, ... Frontiers in Oncology 12, 812560, 2022 | 2 | 2022 |
| MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis S Maji, AK Pradhan, A Kumar, P Bhoopathi, P Mannangatti, C Guo, ... Proceedings of the National Academy of Sciences 120 (45), e2307094120, 2023 | 1 | 2023 |
| Applications of tissue-specific and cancer-selective gene promoters for cancer diagnosis and therapy A Kumar, SK Das, L Emdad, PB Fisher Advances in Cancer Research 160, 253-315, 2023 | 1 | 2023 |
| CRISPR correction of GBA mutation in hiPSCs restores normal function to Gaucher macrophages and increases their susceptibility to Mycobacterium tuberculosis S Ramalingam, A Kumar, S Krug, H Mohan, DN Rao, WR Bishai, ... bioRxiv, 2022.11. 26.517656, 2022 | 1 | 2022 |
| Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter P Bhoopathi, AK Pradhan, A Kumar, S Maji, P Mannangatti, X Deng, ... Cancers 14 (6), 1497, 2022 | 1 | 2022 |
| Iron Oxide Nanozyme in Biomedicine A Kumar, D Acharya, S Satapathy, SK Sahu Iron Oxide-Based Nanocomposites and Nanoenzymes: Fundamentals and …, 2024 | | 2024 |
| Dual targeting of the PDZ1 and PDZ2 domains of MDA-9/Syntenin inhibits melanoma metastasis AK Pradhan, J Modi, S Maji, A Kumar, P Bhoopathi, P Mannangatti, C Guo, ... Molecular Cancer Therapeutics 22 (10), 1115-1127, 2023 | | 2023 |
